Assessing the Safety and Feasibility of Long-Acting Depot of Buprenorphine in Adults Requiring Treatment for Opioid Use Disorder in NSW Custodial Settings
Phase of Trial: Phase II/III
Latest Information Update: 07 Jun 2019
Price : $35 *
At a glance
- Drugs Buprenorphine (Primary) ; Buprenorphine/naloxone; Methadone
- Indications Opioid abuse
- Focus Adverse reactions; Therapeutic Use
- Acronyms DBC; The UNLOC-T Study
- 06 Jun 2019 Planned End Date changed from 27 Dec 2019 to 26 Jun 2020.
- 05 Feb 2019 According to a Camurus media release, top-line results are expected in late 2019.
- 05 Feb 2019 Status changed from not yet recruiting to recruiting, according to a Camurus media release.